REVIEWS AND APPROVALS
Operations personnel delivered six samples from the SHT (MCU-11-1452 through -1457) for analysis. These samples are intended to verify that the solvent is within the specified composition range. The results from the analyses are presented in this document.
Experimental Procedure
Samples were received in p-nut vials containing ~10 mL each. Once taken into the Shielded Cells, the samples were combined. Samples were removed for analysis by density, semi-volatile organic analysis (SVOA), high performance liquid chromatography (HPLC), and Fourier-Transform Infra-Red spectroscopy (FTIR).
Details for the work are contained in a controlled laboratory notebook. 
Results and Discussion
Each of the six p-nut vials contained a single phase, with no apparent solids contamination or cloudiness. Table 1 contains the results of the analyses for the combined samples.
A duplicate density measurement of the organic phase gave a result of 0.844 g/mL (1.2% residual standard deviation -RSD). Using the density as a starting point, we know that the Isopar ® L should be slightly higher than nominal and the other components should be slightly lower than nominal.
The results as a whole are internally consistent. When compared to the MCU density target of 0.845 g/mL, there is no need to add an Isopar ® L trim.  However, it is advisable to add sufficient trioctylamine (TOA) to return  Note that while freshly prepared MCU solvent has a target density of 0.852 g/mL, the MCU facility targets tries to maintain the solvent inventory at 0.845 g/mL in order to prevent over-evaporation.
the solvent composition to within specifications as that component has declined to about 64% the concentration since the last analysis. The TOA measurement was performed twice, so the result is not an analytical aberration. TOA has not been added to the system since the previous quarterly sample in October 2011. 
Conclusions
As with the previous solvent sample results, 4 these analyses indicate that the solvent does not require Isopar ® L trimming at this time. However, addition of TOA is warranted.
These findings indicate that the new protocols for solvent monitoring and control are yielding favorable results. Nevertheless, the deviation in the TOA concentration since the last analysis indicates continued periodic (i.e., quarterly) monitoring is recommended.
